A detailed history of Avanza Fonder Ab transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Avanza Fonder Ab holds 119,661 shares of GILD stock, worth $12.4 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
119,661
Previous 127,115 5.86%
Holding current value
$12.4 Million
Previous $11.7 Billion 14.03%
% of portfolio
0.44%
Previous 0.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 15, 2025

SELL
$89.14 - $117.41 $664,449 - $875,174
-7,454 Reduced 5.86%
119,661 $13.4 Billion
Q4 2024

Jan 15, 2025

BUY
$83.95 - $97.9 $10.7 Million - $12.4 Million
127,115 New
127,115 $11.7 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $130B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Avanza Fonder Ab Portfolio

Follow Avanza Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avanza Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Avanza Fonder Ab with notifications on news.